Tower Research Capital LLC (Trc) Aerie Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.37 - $15.23 $1,484 - $3,548	233 Added 5.67%	4,342 $66,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $17,864 - $33,058	3,609 Added 721.8%	4,109 $31,000
Q1 2022 May 12, 2022	SELL	$5.64 - $9.8 $66,721 - $115,934	-11,830 Reduced 95.94%	500 $5,000
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $64,794 - $123,035	9,230 Added 297.74%	12,330 $87,000
Q3 2021 Nov 15, 2021	SELL	$11.32 - $16.63 $17,149 - $25,194	-1,515 Reduced 32.83%	3,100 $35,000
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $19,404 - $24,281	-1,280 Reduced 21.71%	4,615 $74,000
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $52,689 - $83,934	4,016 Added 213.73%	5,895 $105,000
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $19,051 - $30,269	-2,089 Reduced 52.65%	1,879 $26,000
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $8,096 - $11,192	-774 Reduced 16.32%	3,968 $47,000
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $56,904 - $76,488	4,742 New	4,742 $70,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $31,885 - $68,725	-2,693 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$17.72 - $25.1 $18,978 - $26,882	1,071 Added 66.03%	2,693 $65,000
Q3 2019 Nov 05, 2019	BUY	$18.41 - $28.0 $3,019 - $4,592	164 Added 11.25%	1,622 $31,000
Q2 2019 Aug 13, 2019	BUY	$28.97 - $48.21 $40,500 - $67,397	1,398 Added 2330.0%	1,458 $43,000
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $2,179 - $2,955	60 New	60 $3,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $11,187 - $20,353	-339 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $19,034 - $25,052	339 New	339 $21,000
Q2 2018 Aug 15, 2018	SELL	$47.85 - $70.45 $24,068 - $35,436	-503 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $22,147 - $26,413	433 Added 618.57%	503 $27,000
Q4 2017 Feb 09, 2018	SELL	$50.85 - $65.1 $232,943 - $298,223	-4,581 Reduced 98.49%	70 $4,000
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $226,038 - $279,525	4,651	4,651 $226,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account